Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by tradeaday

V.INT

ortsbo.com website changed

Check out www.ortsbo.com. It has now been updated to reflect the Steve Nash...

June 14, 2011

V.INT

RE: RE: Ortsbo on ABC

The tweet is still there on Ortsbo's twitter web page. But the link...

June 9, 2011

V.INT

RE: Guinness World Record

From the FAQ on the Guiness World Records website: Why is my record...

May 31, 2011

V.INT

Google Translate - API - another official response

Just posted on the INT facebook page: http://www.facebook.com/pages...

May 28, 2011

V.INT

Chart observations

Pull up a chart of INT.V, and plot the 20 day MA on it (currently at 1.43...

May 17, 2011

V.INT

Strategic timing - O4O release

I'm guessing that the release of the Ortsbo Outlook plug-in might very...

May 10, 2011

V.INT

Correction - Revenue scenarios - iPhone app

Sorry, there was a typo in my formulas.  Reposting: ...

May 5, 2011

V.INT

Revenue scenarios - iPhone app

Apple's cut from paid apps in the App store is about 30%. So using some...

May 5, 2011

V.INT

G&M still on the hook - Facebook response

Our Company thankfully is not letting the G&M off the hook so easily for...

May 5, 2011

V.INT

RE: Globe & Mail article "clarification"

And that clarification was just done a few minutes ago! Translating...

May 4, 2011

V.INT

Globe & Mail article "clarification"

The Globe and Mail took the "sell now" out of the title of last...

May 4, 2011

V.INT

RE: iPhone App Approval timeline

Apparently as of 2010, the approval process has gotten much better and more...

May 4, 2011

V.INT

iPhone App Approval timeline

According to this somewhat dated link, 95% of apps for the iPhone are...

May 4, 2011

V.INT

SaaS CEO comments on the G&M

SaaSCEO6:09 PM on May 1, 2011Let me introduce myself. I am the CEO ofSaaS...

May 1, 2011

V.INT

Possible reason for the NR's timing

Let's review what has happened over the last few days and weeks:1. Gene...

April 13, 2011

V.EC

RE: Private Placement Closing

With this closed and filed, I expect a steady climb up to and beyond .30...

April 8, 2011

V.INT

The future for Gene - Priceline/Shatner comparison

A friend found this interesting article. William Shatner took only shares...

April 7, 2011

V.INT

4 NRs per week...

I believe INT is setting up to hit the market with about 3-4 NRs per week...

April 5, 2011

V.EC

RE: RE: RE: RE: RE: Private Placement- Closed yet

Cancelled by the company or the Exchange?  And if cancelled by the...

April 5, 2011

V.EC

RE: RE: RE: Private Placement- Closed yet 31.3.

The PP needs to be filed and approved by the Venture exchange before it can...

April 5, 2011

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

BioVaxys Technology Corp.

BioVaxys Technology Corp. C.BIOV

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ... view more »